Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Mar;63(3):159-63.
doi: 10.1007/s11748-014-0486-7. Epub 2014 Oct 14.

Multimodality treatment for advanced thymic carcinoma: outcomes of induction therapy followed by surgical resection in 16 cases at a single institution

Yasushi Shintani  1 , Masayoshi Inoue, Tomohiro Kawamura, Soichiro Funaki, Masato Minami, Meinoshin Okumura
Affiliations

Multimodality treatment for advanced thymic carcinoma: outcomes of induction therapy followed by surgical resection in 16 cases at a single institution

Yasushi Shintani et al. Gen Thorac Cardiovasc Surg. 2015 Mar.

Abstract

Objective: We reviewed our institutional experience with cases of multimodality treatment for advanced thymic carcinoma to determine patient outcomes and prognostic indicators.

Methods: Between 1998 and 2014, 16 patients with a Masaoka stage III or IV thymic carcinoma underwent surgical resection after induction therapy at Osaka University Hospital. These were considered to have great vessel invasion or metastasis to the mediastinal or intrathoracic lymph nodes based on the preoperative workup findings, and received induction therapy.

Results: Complete tumor resection was achieved in 11 (69%) after the induction therapy. Pathological findings revealed that 10 patients had Masaoka stage III disease, 1 had IVa, and 5 had IVb. The histological diagnosis was squamous cell carcinoma in 13, neuroendocrine carcinoma in 2, and undifferentiated carcinoma in 1. The 5-year survival rate for all patients was 71%. Survival was significantly better in patients who underwent a complete resection (R0 disease) as compared to those with incompletely resected tumors (R1 or R2 disease).

Conclusions: Multimodality treatment offers encouraging results and complete resection provides high survival rate for patients with advanced thymic carcinoma.

PubMed Disclaimer

References

    1. J Thorac Oncol. 2008 Mar;3(3):265-9 - PubMed
    1. Eur J Cardiothorac Surg. 2004 Aug;26(2):401-6 - PubMed
    1. Lung Cancer. 2011 Apr;72(1):68-72 - PubMed
    1. Ann Thorac Surg. 2012 May;93(5):1668-72; discussion 1672-3 - PubMed
    1. Ann Thorac Surg. 2003 Sep;76(3):878-84; discussion 884-5 - PubMed

MeSH terms